Even in well-treated populations, loss to follow-up limits community viral suppression
Tenofovir safe and effective for long-term hepatitis B treatment with little bone loss
Unprotected sex reported by the majority of sexually active adolescents infected with HIV since birth
Sofosbuvir and daclatasvir dual regimen cures most people with HCV genotypes 1, 2, or 3
New fixed-dose combination pills measure up to Atripla - corrected version*
Interferon-free hepatitis C treatment with faldaprevir proves safe and effective in people with cirrhosis
Life expectancy in older people with HIV could exceed the average – as long as ART keeps working
Simeprevir is safe and effective with interferon/ribavirin for hepatitis C patients with cirrhosis
